JP2017025019A - アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 - Google Patents

アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 Download PDF

Info

Publication number
JP2017025019A
JP2017025019A JP2015144319A JP2015144319A JP2017025019A JP 2017025019 A JP2017025019 A JP 2017025019A JP 2015144319 A JP2015144319 A JP 2015144319A JP 2015144319 A JP2015144319 A JP 2015144319A JP 2017025019 A JP2017025019 A JP 2017025019A
Authority
JP
Japan
Prior art keywords
amyloid
earthworm
agent
extract
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015144319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017025019A5 (enExample
Inventor
陽一 石井
Yoichi Ishii
陽一 石井
猛 岡本
Takeshi Okamoto
猛 岡本
さやか 石井
Sayaka Ishii
さやか 石井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Well Stone Co
Original Assignee
Well Stone Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Well Stone Co filed Critical Well Stone Co
Priority to JP2015144319A priority Critical patent/JP2017025019A/ja
Priority to BR112017027209A priority patent/BR112017027209A2/pt
Priority to CN201680016841.9A priority patent/CN107405366B/zh
Priority to RU2018105718A priority patent/RU2018105718A/ru
Priority to KR1020217028697A priority patent/KR20210114551A/ko
Priority to AU2016296962A priority patent/AU2016296962B2/en
Priority to CA2983905A priority patent/CA2983905A1/en
Priority to PCT/JP2016/070902 priority patent/WO2017014162A1/ja
Priority to KR1020217014598A priority patent/KR102302013B1/ko
Priority to EP16827722.6A priority patent/EP3326636A4/en
Priority to US15/577,464 priority patent/US20180147243A1/en
Priority to KR1020227031896A priority patent/KR20220131357A/ko
Priority to KR1020177030221A priority patent/KR102255146B1/ko
Priority to TW105122919A priority patent/TWI781082B/zh
Publication of JP2017025019A publication Critical patent/JP2017025019A/ja
Priority to PH12017501949A priority patent/PH12017501949A1/en
Publication of JP2017025019A5 publication Critical patent/JP2017025019A5/ja
Priority to AU2022200329A priority patent/AU2022200329B2/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/90—Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
    • A23B2/92—Freeze drying
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/16—Potassium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1614—Sodium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/18—Fractionation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2015144319A 2015-07-21 2015-07-21 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 Pending JP2017025019A (ja)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP2015144319A JP2017025019A (ja) 2015-07-21 2015-07-21 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
EP16827722.6A EP3326636A4 (en) 2015-07-21 2016-07-14 MEDIUM FOR THE REMOVAL OF AMYLOID BETA FIBRILLES AND A THERAPEUTIC OR PREVENTIVE AGENT AND THERAPEUTIC OR PREVENTIVE FOOD COMPOSITION FOR DISEASES CAUSED BY AMYLOID BETA FIBRILLATION
US15/577,464 US20180147243A1 (en) 2015-07-21 2016-07-14 Amyloid beta fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid beta fibril formation
RU2018105718A RU2018105718A (ru) 2015-07-21 2016-07-14 СРЕДСТВО, РАЗРУШАЮЩЕЕ ФИБРИЛЛЫ АМИЛОИДА β, И ТЕРАПЕВТИЧЕСКИЙ ИЛИ ПРОФИЛАКТИЧЕСКИЙ АГЕНТ, И ТЕРАПЕВТИЧЕСКАЯ ИЛИ ПРОФИЛАКТИЧЕСКАЯ ПИЩЕВАЯ КОМПОЗИЦИЯ ДЛЯ ЗАБОЛЕВАНИЙ, ВЫЗВАННЫХ ОБРАЗОВАНИЕМ ФИБРИЛЛ АМИЛОИДА β
KR1020217028697A KR20210114551A (ko) 2015-07-21 2016-07-14 아밀로이드β 섬유 분해제, 아밀로이드β의 섬유화에 기인하는 질환의 치료약·예방약 및 치료용·예방용 식품조성물
AU2016296962A AU2016296962B2 (en) 2015-07-21 2016-07-14 Amyloid beta fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid beta fibril formation
CA2983905A CA2983905A1 (en) 2015-07-21 2016-07-14 Amyloid .beta. fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid .beta. fibril formation
PCT/JP2016/070902 WO2017014162A1 (ja) 2015-07-21 2016-07-14 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
KR1020217014598A KR102302013B1 (ko) 2015-07-21 2016-07-14 아밀로이드β 섬유 분해제, 아밀로이드β의 섬유화에 기인하는 질환의 치료약·예방약 및 치료용·예방용 식품조성물
BR112017027209A BR112017027209A2 (pt) 2015-07-21 2016-07-14 agente de decomposição de fibrila beta amiloide e agente terapêutico ou de prevenção e composição alimentícia terapêutica ou de prevenção de doenças causadas pela formação de fibrila beta amiloide
CN201680016841.9A CN107405366B (zh) 2015-07-21 2016-07-14 β淀粉样蛋白纤维分解剂、由β淀粉样蛋白的纤维化引起的疾病的治疗药/预防药
KR1020227031896A KR20220131357A (ko) 2015-07-21 2016-07-14 아밀로이드β 섬유 분해제, 아밀로이드β의 섬유화에 기인하는 질환의 치료약·예방약 및 치료용·예방용 식품조성물
KR1020177030221A KR102255146B1 (ko) 2015-07-21 2016-07-14 아밀로이드β 섬유 분해제, 아밀로이드β의 섬유화에 기인하는 질환의 치료약·예방약 및 치료용·예방용 식품조성물
TW105122919A TWI781082B (zh) 2015-07-21 2016-07-20 澱粉狀蛋白β纖維分解劑、起因於澱粉狀蛋白β之纖維化的疾病之治療藥、預防藥以及治療用、預防用食品組成物
PH12017501949A PH12017501949A1 (en) 2015-07-21 2017-10-25 Amyloid � fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid � fibril formation
AU2022200329A AU2022200329B2 (en) 2015-07-21 2022-01-19 Amyloid beta fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid beta fibril formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015144319A JP2017025019A (ja) 2015-07-21 2015-07-21 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物

Publications (2)

Publication Number Publication Date
JP2017025019A true JP2017025019A (ja) 2017-02-02
JP2017025019A5 JP2017025019A5 (enExample) 2018-10-11

Family

ID=57834025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015144319A Pending JP2017025019A (ja) 2015-07-21 2015-07-21 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物

Country Status (12)

Country Link
US (1) US20180147243A1 (enExample)
EP (1) EP3326636A4 (enExample)
JP (1) JP2017025019A (enExample)
KR (4) KR20210114551A (enExample)
CN (1) CN107405366B (enExample)
AU (2) AU2016296962B2 (enExample)
BR (1) BR112017027209A2 (enExample)
CA (1) CA2983905A1 (enExample)
PH (1) PH12017501949A1 (enExample)
RU (1) RU2018105718A (enExample)
TW (1) TWI781082B (enExample)
WO (1) WO2017014162A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6253837B1 (ja) * 2017-07-18 2017-12-27 エンチーム株式会社 組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010120942A (ja) * 2008-11-22 2010-06-03 Academia Sinica アルツハイマー病、プリオン病、及び他のアミロイド症と関連するアミロイド線維を分解し及び減少させるナットウキナーゼ
WO2013018587A1 (ja) * 2011-07-29 2013-02-07 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末を用いたチロシナーゼ阻害剤およびその製造方法
CN103550537A (zh) * 2013-11-10 2014-02-05 孟晓彬 一种治疗阿尔茨海默病的中药制剂及制备方法
CN104288396A (zh) * 2014-09-27 2015-01-21 隋荣玲 一种治疗老年痴呆症的中药汤剂
CN104547388A (zh) * 2014-12-18 2015-04-29 黑龙江儒泰生物制药有限责任公司 治疗阿尔茨海默病的中药组合物、其制备方法和用途
JP2016088877A (ja) * 2014-11-04 2016-05-23 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283157A (ja) 1995-02-15 1996-10-29 Takeda Chem Ind Ltd アミロイドβ蛋白産生・分泌阻害剤
JP4227245B2 (ja) 1999-04-30 2009-02-18 パナソニック株式会社 磁気ディスク用基板の製造方法
CN1753662A (zh) * 2002-12-24 2006-03-29 神经化学（国际）有限公司 用于治疗β－淀粉状蛋白相关疾病的治疗制剂
ITRM20050045A1 (it) * 2005-02-02 2006-08-03 Consiglio Nazionale Ricerche Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
US8101578B2 (en) 2006-04-28 2012-01-24 Kagoshima University Amyloid [β] Beta fibrillogenesis-inhibiting peptide
JP4699974B2 (ja) * 2006-09-29 2011-06-15 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
US8137701B2 (en) * 2008-03-21 2012-03-20 Well Stone Co. Method of producing a dry earthworm powder
JP2009249362A (ja) * 2008-04-09 2009-10-29 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 無害化されたミミズ乾燥粉末の製造方法
JP4886017B2 (ja) * 2009-10-13 2012-02-29 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
JP4808822B1 (ja) * 2011-04-11 2011-11-02 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
EP3097918B1 (en) * 2014-01-20 2019-04-03 Well Stone Co. Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010120942A (ja) * 2008-11-22 2010-06-03 Academia Sinica アルツハイマー病、プリオン病、及び他のアミロイド症と関連するアミロイド線維を分解し及び減少させるナットウキナーゼ
WO2013018587A1 (ja) * 2011-07-29 2013-02-07 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末を用いたチロシナーゼ阻害剤およびその製造方法
CN103550537A (zh) * 2013-11-10 2014-02-05 孟晓彬 一种治疗阿尔茨海默病的中药制剂及制备方法
CN104288396A (zh) * 2014-09-27 2015-01-21 隋荣玲 一种治疗老年痴呆症的中药汤剂
JP2016088877A (ja) * 2014-11-04 2016-05-23 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
CN104547388A (zh) * 2014-12-18 2015-04-29 黑龙江儒泰生物制药有限责任公司 治疗阿尔茨海默病的中药组合物、其制备方法和用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOSCI. BIOTECHNOL. BIOCHEM., 1999, VOL.63, NO.11, PP.2031-2033, JPN6018036512, ISSN: 0004002487 *

Also Published As

Publication number Publication date
TWI781082B (zh) 2022-10-21
EP3326636A4 (en) 2019-03-27
KR20210114551A (ko) 2021-09-23
US20180147243A1 (en) 2018-05-31
WO2017014162A8 (ja) 2017-11-16
BR112017027209A2 (pt) 2018-10-30
WO2017014162A1 (ja) 2017-01-26
AU2022200329B2 (en) 2023-10-05
RU2018105718A (ru) 2019-08-22
PH12017501949A1 (en) 2018-03-19
KR20180029950A (ko) 2018-03-21
KR20210059023A (ko) 2021-05-24
EP3326636A1 (en) 2018-05-30
AU2016296962B2 (en) 2021-10-28
TW201716073A (zh) 2017-05-16
KR20220131357A (ko) 2022-09-27
CA2983905A1 (en) 2017-01-26
AU2016296962A1 (en) 2018-01-04
AU2022200329A1 (en) 2022-02-17
KR102302013B1 (ko) 2021-09-13
CN107405366A (zh) 2017-11-28
KR102255146B1 (ko) 2021-05-21
CN107405366B (zh) 2022-07-22

Similar Documents

Publication Publication Date Title
JP4808822B1 (ja) ミミズ乾燥粉末の製造方法
JP6195962B2 (ja) カテコールアミン産生促進剤、カテコールアミンの欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
JP6321521B2 (ja) タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
AU2022200329B2 (en) Amyloid beta fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid beta fibril formation
HK1246154B (en) AMYLOID β FIBRIL DECOMPOSING AGENT, AND THERAPEUTIC OR PREVENTIVE AGENT FOR DISEASES CAUSED BY AMYLOID β FIBRIL FORMATION
HK1246154A1 (en) AMYLOID β FIBRIL DECOMPOSING AGENT, AND THERAPEUTIC OR PREVENTIVE AGENT FOR DISEASES CAUSED BY AMYLOID β FIBRIL FORMATION
HK1233168B (zh) 儿茶酚胺产生促进剂，起因於儿茶酚胺的缺乏的疾病的治疗药/预防药

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180828

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20180828

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20180904

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190326